Zuellig Pharma Acquires Cialis® (Tadalafil) from Lilly in three additional markets in Asia
- Written by The Bulletin
SINGAPORE - Media OutReach Newswire - 12 March 2026 - Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has acquired all rights, title, and interest in and to Cialis® (Tadalafil), a leading men's health product from Eli Lilly and Company ("Lilly") in Hong Kong, Macau and South Korea.













